Daniela Rogoff, MD, PhD.

Daniela Rogoff, MD, PhD has a diverse work experience spanning over two decades. Daniela is currently serving as the Sr Vice President of Clinical Development at QED Therapeutics, a position they have held since October 2022. Prior to this role, they held various positions at QED Therapeutics, including VP of Clinical Development and Executive Director, Clinical Development. Before joining QED Therapeutics, Dr. Rogoff worked as a Sr Medical Director at Protagonist Therapeutics from January 2018 to January 2019. Daniela also served as a Senior Medical Director at Versartis, Inc. from February 2016 to October 2017.

Dr. Rogoff's earlier experiences include working as a Medical Director at EMD Serono, Inc. from April 2013 to February 2016, where they focused on fertility and endocrinology in global clinical development. Daniela also worked at EMD Serono as an Associate Medical Director and Senior MSL, specializing in endocrinology and HIV. Dr. Rogoff began their career as a Research Scientist at UT Southwestern Medical Center at Dallas from 2005 to 2010.

Prior to working in the United States, Dr. Rogoff worked as a Pediatric Endocrinologist at Hospital de Niños R. Gutierrez in Buenos Aires, Argentina from 2000 to 2004, where they were involved in assistential and research activities. Before that, they gained valuable research experience as a Postdoctoral Fellow at the National Institutes of Health (NIH) from 2004 to 2005.

Overall, Dr. Daniela Rogoff has a strong background in clinical development, specializing in areas such as endocrinology, fertility, and pediatric endocrinology. Daniela'sextensive experience in both industry and academic settings makes their a highly qualified professional in the field.

Daniela Rogoff, MD, PhD earned their MD,PhD degree from the University of Buenos Aires. The specific field of study during their education is not mentioned.